# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Several top blue-chip stocks sport big dividend yields, but weak cash flow and sector headwinds raise questions of value trap v...
The U.S. Food and Drug Administration (FDA) is set to launch a pilot program to fast-track the review of nicotine pouches from ...
-Reuters
B of A Securities analyst Lisa Lewandowski maintains Altria Group (NYSE:MO) with a Buy and raises the price target from $64 ...